Member Info for Sangijuelas1

That's only for the expansion of the agreement . It was already worth potentially $300m

Another Zacks research note out for $7.50

See Stocktwits for the note

Some word of mouth advertising might be in order

Sorry link on last post more to do with Affyxell- so much going on here hard to get head round it all

You need to see the LG Chem patent thread

This is an interesting article on combining stem cells with immunotherapy
https://www.drugtargetreview.com/article/45241/stem-cell-technologies-in-immunotherapy/

A bit about Us for Them. A bit of astroturfing going on

https://bylinetimes.com/2021/01/21/parents-campaign-against-school-closures-receives-pr-support-from-boris-johnson-advisor/

Not sure if I am getting mixed up with 004 and 04 which is listed on the pipeline but that also seems to be anti PD-L1

PD-L1/PD-1 axis suppresses the immune response in tumours e. g. makes T-cells inactive. This is the checkpoint so anti PD-L1 like Tecentriq is a checkpoint inhibitor that targets this so that the anti tumour T-cells are not inactivated.

Avacta say research in mice shows good safety profile and better pharmo kinetics than Tecentriq

This is a PD-L1 checkpoint inhibitor such as the monoclonal antibody atezolizumab (Tecentriq).

It is part of the preCISION pro drug program and the TMAC drug conjugates one.

Waiting for it to drop below £1 before buying is a form of trading.

A long term investor would buy now and come back in 2-3 years.

You ain't seen nothing yet

You never get a trial start date. There will just be an RNS to say the 1st patients dosed

Market breakers rather than market makers

The 84-87 spread showing is BS. Just there to discourage trades as no doubt MMs haven't got shares

Still got Proventions Teplizumab approval to come next month

As GC said that will be a game changer for anti cd3s

It's oversold the last few months not days

Oversold and underbought

The Avacta BB is the only place I have ever seen this issue raised

I have been saying this since forever.

People get confused with vaccine efficacy against the new variants and think it applies to tests as well

99% of all new cases are Delta and they are being detected in their thousands every day by the existing LFTs

They don't need to work on an affimer to detect Delta.

The current test will detect it in the same way that other tests on the market are detecting it with no problem.

Given the news it is under bought